Drug intelligence / Profile preview

curdepsidone A

Development stage
Preclinical
Lead developer
Curvularia sp. IFB-Z10 (fungal source)
Modality
Small Molecules
Administration
In Vitro
01

Overview

Curdepsidone A is a natural depsidone isolated from the marine-derived endophytic fungus Curvularia sp. IFB-Z10. It exhibits potent anti-tumor activity, particularly against human cervical cancer cells (HeLa), where it induces G0/G1 phase cell cycle arrest and promotes apoptosis through the mitochondrial pathway. Its mechanism involves inhibition of protective autophagy, elevation of intracellular reactive oxygen species (ROS), and suppression of PI3K/AKT signaling. These combined actions lead to anti-proliferative and pro-apoptotic effects in various tumor cell lines, with the greatest sensitivity seen in HeLa cells. Structure revision and mechanistic studies suggest potential for development as a chemotherapy agent for cervical cancer[1][3][5][4].

Other names
2,7-dihydroxy-9-methoxy-4,10-dimethyl-6-oxobenzo[b][1,4]benzodioxepine-8-carboxylic acid
02

Targets

CDK4 (Cyclin-dependent kinase 4)CDKN1B (Transmembrane emp24 domain-containing protein 7)CDKN1A (Cyclin-dependent kinase inhibitor 1A)CCND1 (Cyclin D1)

Beyond the preview

Go deeper on curdepsidone A.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on curdepsidone A.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call